Dementia and Movement Disorders Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Request Brochure Request Discount

Report Code: ZMR-3009 | Report Format : | Status : Upcoming |

Abstract

Global Dementia and Movement Disorders Market: Overview

Dementia is mainly recognized as mental illnesses, which can lead to degeneration of the capability to remember or think in an individual. As a result, the syndrome is only treated symptomatically. However, in several cases movement disorders are also observed, for instance, Parkinson’s are recognized to be a medium for dementia. Based on the research around 80% of individuals with Parkinson’s or other movement syndromes are likely to develop cognitive issues.

Global Dementia and Movement Disorders Market: Growth Factors

Global dementia and movement disorders market is driven by a quickly expanding geriatric populace highly susceptible to different neurodegenerative syndromes. In addition to this, other major aspects which are slated to optimistically impact the market are a frequent partnership among pharmaceutical companies, research organizations, drug and device manufacturing firms, and medical institutes. These collaborations have resulted in tremendous R&D efforts aimed at the discovery of effective treatment options for the condition of dementia & movement disorders.

The global market is, however, affected by many restraints that threaten to obstruct its expansion in the coming years. A key restraining aspect is a limited knowledge regarding brain mechanisms as well as the various neurodegenerative syndromes. Furthermore, management solutions for neurological disorders, the absence of comprehensive therapeutics, drug failures in late-stage clinical trials, lengthy approval time for drugs, rigid regulatory requirements and devices act as deterrents to the development of the market for global dementia and movement disorders market.

Global Dementia and Movement Disorders Market: Segmentation

Global dementia and movement disorders market can be classified in terms of drugs utilized for movement disorders & progressive dementia with other neurological abnormalities and treatment of progressive dementia. Amongst these, the division of drugs majorly used in the treatment of progressive dementia is categorized as diseases based therapeutics in progressive dementia and drugs for progressive dementia. Furthermore, the division of drugs utilized with other different neurological abnormalities to treat progressive dementia is fragmented into disease-based therapeutics with other neurological abnormalities and drugs with other neurological abnormalities for progressive dementia under progressive dementia. Also, the division of drugs utilized for treating movement disorders is divided into diseases based therapeutics and drugs for movement disorders in movement disorders.

Global Dementia and Movement Disorders Market: Regional Analysis

North America is likely to account for a momentous share in the global market, driven mainly by the high occurrence rate of the neurodegenerative syndrome, also resulting in a large number of individuals living with limited mobility. With considerably aging inhabitants, the number of individuals afflicted by different neurological syndromes has augmented. The market for dementia and movement disorders in Europe is likely to be the strong contender in the overall development and is likely to be propelled by similar aspects.

The Asia Pacific is projected to register significant expansion rate in the coming future with a growing number of responsiveness programs particularly initiated by private as well as public healthcare institutions. A huge population base, which includes geriatrics and increasing healthcare insurance coverage is likely to be responsible for the anticipated expansion of the Asia Pacific region for global dementia and movement disorders market.

Global Dementia and Movement Disorders Market: Competitive Players

Some of the most important market players in the global dementia and movement disorders market are Valeant Pharmaceutical International, Pfizer, Hoffmann-La Roche, Novartis AG, AstraZeneca GmbH, Sanofi S.A., and Merck & Co., among others.

Global Dementia and Movement Disorders Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3439 | Report Format:

The report covers forecast and analysis for the peptide therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the peptide therape...Read More

Cognitive and Memory Enhancer Drugs Market by Drug Type (Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others) and Application (Disease Treatment, Academic Performance, Athletic Performance and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 –2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3429 | Report Format:

The report covers forecast and analysis for the cognitive and memory enhancer drugs market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints ...Read More

Connected Healthcare Market by Function (Telemedicine, Home Monitoring, Assisted Living, and Clinical Monitoring), by Type (e-Prescription, mHealth Services, and mHealth Devices), and Application (Diagnosis & Treatment, Monitoring Applications, Education & Awareness, Wellness & Prevention, Healthcare Management, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3417 | Report Format:

The report covers forecast and analysis for the connected healthcare market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the connected healthcare ma...Read More

Kidney Stones Management Market by Diagnostics (Computed Tomography Scan, Abdominal X-ray, Ultrasound, Intravenous Pyelography, Abdominal MRI, and Others), by Type (Calcium Oxalate, Uric Acid, Calcium Phosphate, Cysteine, and Struvite), and by Treatment (Extracorporeal shock wave lithotripsy, Percutaneous Nephrolithotomy, Ureteroscopy, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3412 | Report Format:

The report covers forecast and analysis for the kidney stones management market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the kidney stones manag...Read More

Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2026

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3400 | Report Format:

The report covers forecast and analysis for the tissue diagnostic market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue diagnostic ma...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.